PharmaCyte Biotech reports FQ2 results

Dec. 15, 2021 9:08 AM ETPharmaCyte Biotech, Inc. (PMCB) StockBy: Meghavi Singh, SA News Editor
  • PharmaCyte Biotech (NASDAQ:PMCB): FQ2 cash on hand of approximately $87 million as of October 31, 2021.
  • Press Release

Recommended For You

More Trending News

About PMCB Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PMCB--
PharmaCyte Biotech, Inc.